ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS

• How Pfizer Used Wearable DHTs To Reveal Meaningful Treatment Effects In Cancer Cachexia

  Wearable digital health technologies (DHTs) played a crucial role in assessing patient-centric outcomes during pfizer's study into the benefits of using ponsegromab for treating cancer cachexia.

• The New Standard In Participant-Centric Trials

  Clinical technology must serve both scientific rigor and human experience—and Castor is positioning itself at the forefront of this participant-led future.

• Advancing Patient-Centric Research With DHTs

  Sleep quality is pivotal for overall health. Explore how wearable digital health technologies can revolutionize our understanding of sleep and enhance research outcomes.

• Avoid Database Go-Live Delays With The Right EDC System

  If you are looking to speed up your start-up process, selecting a reliable EDC System is key.

• Hope In The Dark: Value In Alzheimer's Disease Research And Treatment

  The May/June 2025 issue of Value & Outcomes Spotlight explores the health economics and outcomes research (HEOR) and its contribution to research and treatment of Alzheimer’s disease.

• Is The Industry Ready To Trust LLMs With Chart Review?

  See how LLM-powered extraction transforms unstructured medical records into compliant, audit-ready clinical data with machine-scale speed, human oversight, and regulatory-grade accuracy.

• The Impact Of Automation In The Monitoring And Reporting Process

  As clinical trial costs rise and ROIs decline, research teams are turning to automation to streamline monitoring and reporting processes without compromising data quality or regulatory compliance.

   

• Digital Medicine Society Accelerates Recruitment and Results With eConsent

  Find out how the Digital Medicine Society (DiMe), an interdisciplinary professional society for digital medicine, was able to deploy an eConsent module in less than two weeks to support its remote study to assess nocturnal scratching as an endpoint for patients.

• Endpoint Reliability And eCOA Solutions Facilitate CNS Trial Success

  A Japan-based pharmaceutical development company utilized Signant's eCOA solutions and knowledge to ensure the reliability of endpoints in their Phase 3 and extended-duration CNS trials.

• Discover Why Electronic Revisions Of ICFs Are Easier

  What does the ICF amendment or revision process look like within a digital platform and is this harder or easier than traditional paper-based approaches?